Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GlaxoSmithKline-plc-GSK-and-Theravance-announce-FDA-acceptance-of-FF-VI-New-Drug-Application-NDA-15225910/?utm_source=whatsapp&utm_medium=social&utm_campaign=share